PART 4. Effects of extremely low frequency electromagnetic fields on the tumor cell inhibition and the possible mechanism

Jul 16, 2025 Leave a message

PART 4. Effects of extremely low frequency electromagnetic fields on the tumor cell inhibition and the possible mechanism

info-1437-249

trypsin (optimal digestion time varied from cell to cell: 293 T, 1 min; Hepg2, 1 min; A549, 2 min). The digestion
was terminated in the medium, and all cells were added to the centrifuge tube. Then, the hole was cleaned with
normal saline many times and added to the centrifuge tube. At this time, the centrifuge tube contained all cells.
Whether cells were left in the hole was observed under the microscope.
Suspended cells: All cell suspensions were placed in a centrifuge tube. The holes were washed with normal
saline several times and placed in the centrifuge tube. At this time, the centrifuge tube contained all cells. The
pores were observed for cell residue under the microscope.
Counting: The cells were centrifuged, resuspended in an appropriate medium, diluted partially, and stained
with Trypan blue. Then, 10 µL of it was injected through the cover glass.
Calculation formula: Number of cells/4×volume×dilution ratio× 104 .
The cells in each group were counted three times for a total of three groups.
 
pH value detection . The membrane-permeable fluorescence dye BCECF AM and pH-sensitive fluores
cent probe 2',7'-bis-(2-carboxyethyl)-5-carboxyfluorescein (Beyotime Biotechnology, China) were used to assess
the intracellular pH value. The cells were cultured in 96-well plates and exposed to a 5-mT, 20-Hz magnetic field
for 2 h on the first 2 days. On day 3, the cells were resuspended in 100 µL of 25 µM BCECF AM in 0.04% Pluronic
F-127 working solution and incubated in a CO2 incubator at 37±0.18 °C for 1 h. The supernatant was replaced
with HHBS buffer (AAT Bioquest, USA), and the cells were subjected to magnetic field exposure for 2 h. The
supernatant was then replaced with PBS, and the pH values were determined using FITC flow cytometry (FACS
Calibur, BD).
 
Intracellular calcium concentration assays. The membrane-permeable fluorescence dye Calbryte
520 AM (AAT Bioquest) was used to assess the intracellular calcium concentration. The cells were cultured in
96-well plates and exposed to a 5-mT, 20-Hz magnetic field for 2 h on the first 2 days. On day 3, the cells were
resuspended in 100 µL of 5 µM Calbryte 520 AM in 0.04% Pluronic F-127 working solution and incubated in a
CO2 incubator at 37±0.18 °C for 1 h. The supernatant was replaced with HHBS buffer (AAT Bioquest), and the
cells were exposed to the magnetic field for 2 h. The supernatant was then replaced with PBS, and the intracel
lular calcium concentration values were determined using FITC flow cytometry (FACS Calibur).
 
Determination of membrane potential of cells. The membrane potential was determined using the
potential-sensitive fluorescence dye bis-(1,3-dibutylbarbituric acid) trimethine oxonol (DiBAC4) (3) (AAT Bio
quest). The fluorescent dye DiBAC4 (3) permeated into the depolarized cells with high membrane potential,
leading to an increase in the intracellular fluorescence intensity. DiBAC4 (3) was discharged from the hyperpo
larized cells, and the intracellular fluorescence intensity decreased. The cells were cultured in 96-well plates and
exposed to a 5-mT, 20-Hz magnetic field for 2 h on the first 2 days. The cells were cultured in 100 µL of HHBS.
On day 3, the cells were resuspended in 100 µL of 10 µM DIBAC4 (3) AM in 0.04% Pluronic F-127 working solu
tion and incubated in a CO2 incubator at 37±0.18 °C for 1 h. The supernatant was replaced with HHBS buffer
(AAT Bioquest), and the cells were exposed to the magnetic field for 2 h. The supernatant was then replaced with
PBS, and the cell membrane potentials were determined using FITC flow cytometry (FACS Calibur).
 
Sodium ion detection. The cells were cultured in 96-well plates and exposed to a 5-mT, 20-Hz magnetic
field for 2 h on the first 2 days. On day 3, the medium was replaced with 100 µL of HHBS and 100 µL of 10 µM
SBFI AM (Cayman Chemical) in a 0.04% Pluronic F-127 working solution. The supernatant was replaced with
HHBS buffer (AAT Bioquest) after 4-h incubation in a CO2 incubator at 37±0.18 °C, and the cells were exposed
to the magnetic field for 2 h. The sodium ion was determined at 330/80 excitation and 528/20 emission using a
microplate tester.
info-1427-80
Potassium ion detection. The cells were cultured in 96-well plates and exposed to a 5-mT, 20-Hz mag
netic field for 2 h on the first 2 days. On day 3, the medium was replaced with 100 µL of HHBS and 100 µL of
10 µM PBFI AM (Cayman Chemical) in a 0.04% Pluronic F-127 working solution. After 4-h incubation in a CO2
incubator at 37±0.18 °C, the supernatant was replaced with HHBS buffer (AAT Bioquest), and the cells were
exposed to the magnetic field for 2 h. The potassium ion determination was conducted at 330/80 excitation and
528/20 emission using a microplate tester.
 
Trypan blue dyeing. 293 T, Hepg2, and A549 cells in the logarithmic growth phase were trypsin digested
and harvested. Raji cells were collected directly. Following centrifugation, the cells were stained with the vital
dye Trypan blue. The live cells were counted under an inverted light microscope (Carl Zeiss, Germany). The cell
growth inhibition rates were determined, and representative curves were plotted. Inhibition rate (%)=(num
ber of cells in the control group−number of cells in the magnetic field group) / number of cells in the control
group×100%.
 
Statistical analysis. All data were expressed as mean±standard error of the mean, and one-way analysis of
variance was used for comparison between multiple groups. The Student t test was used to compare the treated
versus untreated groups. A P value<0.05 indicated a statistically significant difference. The confirmatory results
at P<0.05 were obtained from repeating studies at least two times. Each set of experiments had three parallel
samples and each experiment was repeated three times.
 
Data availability
All data are presented in this published article and supplementary file.
info-1413-85
References
1. Zhang, X. et al. Magnetic fields at extremely low-frequency (50 Hz, 0.8 mT) can induce the uptake of intracellular calcium levels
in osteoblasts. Biochem. Biophys. Res. Commun. 396(3), 662–666 (2010).
2. Li, J. et al. Natural static magnetic field-induced apoptosis in liver cancer cell. Electromagn Biol. Med. 33(1), 47–50 (2014).
3. Koh, E. K. et al. A 60-Hz sinusoidal magnetic field induces apoptosis of prostate cancer cells through reactive oxygen species. Int.
J. Radiat. Biol. 84(11), 945–955 (2008).
4. Cameron, I. L. et al. Therapeutic electromagnetic field (TEMF) and gamma irradiation on human breast cancer xenograft growth,
angiogenesis and metastasis. Cancer Cell Int. 5, 23 (2005).
5. de Seze, R. et al. Effects of 100 mT time varying magnetic fields on the growth of tumors in mice. Bioelectromagnetics 21(2), 107–111
(2000).
6. Novikov, V. V., Novikov, G. V. & Fesenko, E. E. Effect of weak combined static and extremely low-frequency alternating magnetic
fields on tumor growth in mice inoculated with the Ehrlich ascites carcinoma. Bioelectromagnetics 30(5), 343–351 (2009).
7. Tatarov, I. et al. Effect of magnetic fields on tumor growth and viability. Comp. Med. 61(4), 339–345 (2011).
8. Tofani, S. et al. Increased mouse survival, tumor growth inhibition and decreased immunoreactive p53 after exposure to magnetic
fields. Bioelectromagnetics 23(3), 230–238 (2002).
9. Tofani, S. et al. Static and ELF magnetic fields induce tumor growth inhibition and apoptosis. Bioelectromagnetics https://doi.org/
10.1002/bem.69 (2001).
10. Williams, C. D. et al. Therapeutic electromagnetic field effects on angiogenesis and tumor growth. Anticancer Res. 21(6A), 3887–
3891 (2001).
11. Yamaguchi, S. et al. Effects of pulsed magnetic stimulation on tumor development and immune functions in mice. Bioelectromag
netics 27(1), 64–72 (2006).
12. Berg, H. et al. Bioelectromagnetic field effects on cancer cells and mice tumors. Electromagn Biol. Med. 29(4), 132–143 (2010).
13. Liang, Y. et al. Enhanced potency of daunorubicin against multidrug resistant subline KB-ChR-8-5-11 by a pulsed magnetic field.
Anticancer Res. 17(3C), 2083–2088 (1997).
14. Omote, Y. et al. Treatment of experimental tumors with a combination of a pulsing magnetic field and an antitumor drug. Jpn. J.
Cancer Res. 81(9), 956–961 (1990).
15. Xu, L. et al. Synergistic inhibitory effect of static magnetic field and antitumor drugs on Hepa1-6 cells. Sheng Wu Gong Cheng Xue
Bao 31(9), 1363–1374 (2015).
16. Gellrich, D., Becker, S. & Strieth, S. Static magnetic fields increase tumor microvessel leakiness and improve antitumoral efficacy
in combination with paclitaxel. Cancer Lett. 343, 107–114 (2014).
17. El-Bialy, N. S. & Rageh, M. M. Extremely low-frequency magnetic field enhances the therapeutic efficacy of low-dose cisplatin in
the treatment of Ehrlich carcinoma. Biomed. Res. Int. 2013, 189352 (2013).
18. Gellrich, D. et al. Modulation of exposure to static magnetic field affects targeted therapy of solid tumors In Vivo. Anticancer Res.
38, 4549–4555 (2018).
19. Crocetti, S. et al. Low intensity and frequency pulsed electromagnetic fields selectively impair breast cancer cell viability. PLoS
ONE 8(9), e72944 (2013).
20. Raylman, R. R., Clavo, A. C. & Wahl, R. L. Exposure to strong static magnetic field slows the growth of human cancer cells in vitro.
Bioelectromagnetics 17(5), 358–363 (1996).
21. Wang, T. et al. Involvement of midkine expression in the inhibitory effects of low-frequency magnetic fields on cancer cells. Bio
electromagnetics 32(6), 443–452 (2011).
22. Buckner, C. A. et al. Inhibition of cancer cell growth by exposure to a specific time-varying electromagnetic field involves T-type
calcium channels. PLoS ONE 10(4), e0124136 (2015).
23. Wang, M. H. et al. Effect of extremely low frequency electromagnetic field parameters on the proliferation of human breast cancer.
Electromagn. Biol. Med. 40(3), 384–392 (2021).
24. Kim, S. H. et al. Toxicity bioassay in Sprague–Dawley rats exposed to 20 kHz triangular magnetic field for 90 days. Bioelectromag
netics 27(2), 105–111 (2006).
25. Ashdown, C. P. et al. Pulsed low-frequency magnetic fields induce tumor membrane disruption and altered cell viability. Biophys.
J. 118, 1552–1563 (2020).
26. Watson, J. M., Parrish, E. A. & Rinehart, C. A. Selective potentiation of gynecologic cancer cell growth in vitro by electromagnetic
fields. Gynecol. Oncol. 71(1), 64–71 (1998).
27. Zhou, Y. et al. Signal transduction. Membrane potential modulates plasma membrane phospholipid dynamics and K-Ras signaling.
Science 349, 873–876 (2015).
28. Berzingi, S., Newman, M. & Yu, H. G. Altering bioelectricity on inhibition of human breast cancer cells. Cancer Cell Int. 16, 72
(2016).
29. Leslie, T. K. et al. Sodium homeostasis in the tumour microenvironment. Biochim. Biophys. Acta Rev. Cancer 1872(2), 188304
(2019).
30. Wang, X. X. et al. Large-scale DNA methylation expression analysis across 12 solid cancers reveals hypermethylation in the
calcium-signaling pathway. Oncotarget 8(7), 11868–11876 (2017).
 
info-1439-81
Acknowledgements
We thank Professor Peter K. Law from The Cell Therapy Institute, Wuhan, China, for technical assistance.
 
Author contributions
J.S. designed the study, performed most of the experiments, analysed data and wrote the manuscript. H.W.
advised on experiment design and helped with experiments. Y.J., X.J., Y.C and Y.Y.T. participated in study design
and performed experiments.W.Y.J. commented on the manuscript. Z.M, K.C, X.D.L, Z.L.C and J.M.W partici
pated in the production and measurement of magnetic field instruments. G.H.Y. designed and supervised the
study, interpreted data and wrote the manuscript.
 
Funding
The Special fund for cancer prevention and treatment of Shanghai Science and Technology Development Foun
dation (Grant number CT20200517A).
 
Competing interests
The authors declare no competing interests.
 
Additional information
Supplementary InformationThe online version contains supplementary material available at https://doi.org/
10.1038/s41598-023-34144-5.
 
Correspondence and requests for materials should be addressed to G.Y.
 
Reprints and permissions information is available at www.nature.com/reprints.
 
Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and
institutional affiliations.
 
info-113-43Open Access This article is licensed under a Creative Commons Attribution 4.0 International
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the
Creative Commons licence, and indicate if changes were made. The images or other third party material in this
article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the
material. If material is not included in the article's Creative Commons licence and your intended use is not
permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from
the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2023info-1421-85

Send Inquiry

whatsapp

Phone

E-mail

Inquiry